Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2023-A01439-36 | Other Identifier | ANSM |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Nearly half of all intensive care patients describe symptoms of anxiety and depression after a stay in the ICU, and one in five has genuine post-traumatic stress disorder.
As a result, improving patient experience has become a priority in the ICU, and particular attention is being paid to the need to recreate a familiar environment.
Animal-mediated interventions have been developed for a number of patients over many years. These strategies are widely used with elderly patients, and patients with cognitive or psychiatric disorders, for whom the literature shows benefits on anxiety, mood or objective signs of stress.
In the vast majority of experiments carried out to date, the animals (mainly dogs) were prepared and educated for contact with patients, and their handlers trained in this activity, rather like guide dogs. Visiting a care facility with a patient's own pet is rarely described. It may run up against obstacles related to the animal's behavior or infectious risks, but it is nevertheless authorized in many establishments.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pet visit | Experimental | Intensive care patients visited by their pets for 20 minutes |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pet visit | Other | Intensive care patients visited by their pets for 20 minutes |
|
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility of visiting the pets | The feasibility of visiting the pets of patients hospitalized in the intensive care unit will be measured by the proportion of patients included in the study for whom at least one visit with their pet was possible. A visit will be considered to have taken place as soon as the patient has had contact with his or her pet. | Day 15 |
| Measure | Description | Time Frame |
|---|---|---|
| PANAS | The impact of the animal's visit on the patient's mood will be assessed by variations in the scale Positive and Negative Affect Schedule (PANAS). This self-report scale measures positive (PA) and negative (NA) affect, and is made up of 20 items, 10 of which assess PA and 10 of which assess NA. Each item refers to an adjective, and responses are classified on a 5-point Likert scale, according to how the person felt about the emotion described by the adjective. For each patient, the variation in AP and NA is calculated as follows: (score after visit-score before visit)/score before visit. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Guillaume THIERY, PhD | Contact | 0477127862 | 33 | guillaume.thiery@chu-st-etienne.fr |
| Cindy POKRANDT | Contact | Cindy.POKRANDT@chu-st-etienne.fr |
| Name | Affiliation | Role |
|---|---|---|
| Cindy POKRANDT | Centre Hospitalier Universitaire de Saint Etienne | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centre Hospitalier Ardèche Nord | Not yet recruiting | Annonay | 07100 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients who can be visited by their pets
Not provided
Not provided
Not provided
Not provided
| Day 1 |
| Paramedical care | The evaluation of the paramedical care load will be assessed by 2 quantitative indicators:
| Day 1 |
| Patient microbiological impact | Search for multi-resistant bacteria on rectal and nasal swabs taken from patients on a routine weekly basis (Meticillin-resistant Staphylococcus Aureus, ESBL-producing Enterobacteria, Vancomycin-resistant Enterococcus, Carbapenemase-producing Enterobacteria). Stool analysis, in particular for Clostridium Difficile and Salmonella, and bacterial and parasitic research by multiplex PCR. | Day 1 |
| Intensive care unity microbiological impact | Surface samples will be taken in conjunction with the operational hygiene team before and after the animal visit, in the room where the visit takes place, in the room of each patient included after discharge, and in the care areas of the intensive care unit. These samples will focus on bacteria, fungi and parasites. | Day 1 |
| Patient satisfaction | Satisfaction survey | 3 months |
| Centre Hospitalier de Saint-Etienne | Recruiting | Saint-Etienne | 42055 | France |
|